Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hruby

Showing results (71-80 of 762) with videos related to

Pageof 77
Sort By:
Trends in Pharmacological Sciences|December 5, 2003
Techniques: plasmon-waveguide resonance (PWR) spectroscopy as a tool to study ligand-GPCR interactionsGordon Tollin, Zdzislaw Salamon, Victor J Hruby
Neuroscience Letters|November 18, 2006
Antihyperalgesic effects of loperamide in a model of rat neuropathic pain are mediated by peripheral delta-opioid receptorsKatsumi Shinoda, Victor J Hruby, Frank Porreca
Acta Crystallographica. Section C, Crystal Structure Communications|July 15, 1992
The absolute configuration of an intermediate in the asymmetric synthesis of unusual amino acidsR Dharanipragada, M Bruck, V J Hruby
The Journal of Peptide Research : Official Journal of the American Peptide Society|October 19, 2001
Fast, efficient and selective deprotection of the tert-butoxycarbonyl (Boc) group using HCl/dioxane (4 m)G Han, M Tamaki, V J Hruby
International Journal of Peptide and Protein Research|August 1, 1991
Synthetic glucagon antagonists and partial agonistsC Zechel, D Trivedi, V J Hruby
The American Journal of Physiology|November 1, 1990
mechanism of glucagon choleresis in guinea pigsR Lenzen, V J Hruby, N Tavoloni
Immunopharmacology and Immunotoxicology|October 17, 2014
Cancer vaccine adjuvants--recent clinical progress and future perspectivesAbid H Banday, Salika Jeelani, Victor J Hruby
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|May 2, 1998
Gradient- and sensitivity-enhanced TOCSY experimentsK E Kövér, D Uhrín, V J Hruby
The Journal of Biological Chemistry|September 25, 1978
A reassessment of structure-function relationships in glucagon. Glucagon1-21 is a full agonistD E Wright, V J Hruby, M Rodbell
Life Sciences|September 26, 1983
Re-evaluation of glucagon1-6: the N-terminal hexapeptide of glucagon is not biologically active in the hepatic adenylate cyclase systemJ T Pelton, D Trivedi, V J Hruby
Pageof 77

Showing results (71-80 of 762) with videos related to

Sort By:
Pageof 77
Trends in Pharmacological Sciences|December 5, 2003
Techniques: plasmon-waveguide resonance (PWR) spectroscopy as a tool to study ligand-GPCR interactionsGordon Tollin, Zdzislaw Salamon, Victor J Hruby
Neuroscience Letters|November 18, 2006
Antihyperalgesic effects of loperamide in a model of rat neuropathic pain are mediated by peripheral delta-opioid receptorsKatsumi Shinoda, Victor J Hruby, Frank Porreca
Acta Crystallographica. Section C, Crystal Structure Communications|July 15, 1992
The absolute configuration of an intermediate in the asymmetric synthesis of unusual amino acidsR Dharanipragada, M Bruck, V J Hruby
The Journal of Peptide Research : Official Journal of the American Peptide Society|October 19, 2001
Fast, efficient and selective deprotection of the tert-butoxycarbonyl (Boc) group using HCl/dioxane (4 m)G Han, M Tamaki, V J Hruby
International Journal of Peptide and Protein Research|August 1, 1991
Synthetic glucagon antagonists and partial agonistsC Zechel, D Trivedi, V J Hruby
The American Journal of Physiology|November 1, 1990
mechanism of glucagon choleresis in guinea pigsR Lenzen, V J Hruby, N Tavoloni
Immunopharmacology and Immunotoxicology|October 17, 2014
Cancer vaccine adjuvants--recent clinical progress and future perspectivesAbid H Banday, Salika Jeelani, Victor J Hruby
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|May 2, 1998
Gradient- and sensitivity-enhanced TOCSY experimentsK E Kövér, D Uhrín, V J Hruby
The Journal of Biological Chemistry|September 25, 1978
A reassessment of structure-function relationships in glucagon. Glucagon1-21 is a full agonistD E Wright, V J Hruby, M Rodbell
Life Sciences|September 26, 1983
Re-evaluation of glucagon1-6: the N-terminal hexapeptide of glucagon is not biologically active in the hepatic adenylate cyclase systemJ T Pelton, D Trivedi, V J Hruby
Pageof 77